BOSTON SCIENTIFIC CORPORATION PFR KIT PINNACLE LITE POSTERIOR; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN
|
Back to Search Results |
|
Model Number M0068317150 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erosion (1750); Incontinence (1928); Injury (2348); Constipation (3274); Unspecified Mental, Emotional or Behavioural Problem (4430); Dyspareunia (4505)
|
Event Date 01/31/2014 |
Event Type
Injury
|
Manufacturer Narrative
|
Date of event was approximated to (b)(6) 2014, implant date, as no event date was reported.Bl this event was reported by the patient's legal representation.The device was implanted at: (b)(6).(b)(4).The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|
|
Event Description
|
It was reported to boston scientific corporation that a pfr kit pinnacle lite posterior was implanted into the patient during a procedure performed on january 31, 2014.As reported by the patient's attorney, after the implantation, the patient had experienced an unknown injury.The patient was also implanted with a non-bsc device on (b)(6) 2014.Boston scientific has been unable to obtain additional information regarding the event to date.
|
|
Event Description
|
It was reported to boston scientific corporation that a pfr kit pinnacle lite posterior was implanted into the patient during a procedure performed on (b)(6) 2014.The patient was also implanted with a non-bsc device on (b)(6) 2014.Patient symptoms include: eep (erosion/extrusion/protrusion of the mesh); back pain; vaginal pain; pelvic pain; groin pain; inability to have intercourse; difficulties with bowel motions; incontinence not present before implant; recurrent incontinence; aggravated incontinence; psychiatric injury.Nonsurgical treatments: on (b)(6) 2015 the patient commenced pain medication: panodol for the treatment of: bladder and back pain.Treatment duration: ongoing.On (b)(6) 2015 the patient commenced incontinence medication: incontinence pads for the treatment of: incontinence.Treatment duration: ongoing.The patient was treated with topical treatment (including oestrogen cream): oestrogen for the treatment of: vaginal dryness.Treatment duration: ongoing.
|
|
Manufacturer Narrative
|
Block b3 date of event: date of event was approximated to january 31, 2014, implant date, as no event date was reported.Block e1: this event was reported by the patient's legal representation.The device was implanted by: dr.(b)(6).(b)(6) hospital.Block h6: patient code e2006, e1405, e0206 and e2330 captures the reportable event of erosion, dyspareunia, unspecified mental, emotional or behavioural problem and pain.Impact codes f12 and f2303 captures the reportable event of serious injury/ illness/ impairment and medication required.Block h10: the complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: block e1: physician's information has been added.Block b5 has been updated.Block h6: patient and impact code are updated.
|
|
Search Alerts/Recalls
|
|
|